Navigating Site Selection For Cell & Gene Therapy Studies

Studies often depend on a mix of experienced Tier I academic centers and more accessible Tier II sites to balance expertise with patient reach. Factors such as genetic testing capabilities, logistical readiness, and long-term follow-up models play a critical role in identifying suitable locations. As trial demands grow, a flexible and well-informed site strategy is essential to ensure timely recruitment and diverse patient participation.